While several studies demonstrate increases in the prevalence of interstitial lung disease (ILD) and diffuse pan-bronchiolitis in RA patients with DR4 [8–10], others have shown that DR4 exerts a protective effect against RA-ILD [10]. The gene discussed is TNFRSF10A; the disease is interstitial lung disease.